{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:48:14Z","timestamp":1791913694297,"version":"4.3.4"},"reference-count":145,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canrad.2026.104876","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:48:16Z","timestamp":1790182096000},"page":"104876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["General technical considerations on reirradiation and focus on brain and head and neck tumours, suggestions from the Recommendations Commission of the Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique"],"prefix":"10.1016","volume":"30","author":[{"given":"Alexandre","family":"Escande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuedan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Guimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Sunyach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Beddok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2026.104876_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102582","article-title":"Management of reirradiations: a clinical and technical overview based on a French survey","volume":"109","author":"Ayadi","year":"2023","journal-title":"Phys Med"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.semradonc.2020.11.009","article-title":"Reirradiation of recurrent non-small cell lung cancer","volume":"31","author":"Hunter","year":"2021","journal-title":"Semin Radiat Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2026.104876_bib0015","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110587","article-title":"Consistency in reirradiation scenarios: terminology, tissue recovery in calculations, units and reporting","volume":"202","author":"West","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110184","article-title":"Multicentre evaluation of variation in cumulative dose assessment in reirradiation scenarios","volume":"194","author":"Hardcastle","year":"2024","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ijrobp.2025.03.002","article-title":"Reirradiation special medical physics consultations: lessons learned from nearly 3000 courses of treatment","volume":"122","author":"Paradis","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.adro.2019.05.007","article-title":"The special medical physics consult process for reirradiation patients","volume":"4","author":"Paradis","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0040","first-page":"392","article-title":"D\u00e9fis organisationnels, m\u00e9thodologiques et techniques relatifs aux r\u00e9-irradiations en radioth\u00e9rapie","volume":"10","author":"Ayadi","year":"2024","journal-title":"Innov Ther Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0045","article-title":"Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results","volume":"36","author":"Ayadi","year":"2025","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0050","first-page":"630","article-title":"Reirradiation: standards, challenges, and patient-focused strategies across tumor types","volume":"75","author":"Beddok","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2026.104876_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109585","article-title":"Challenges of reirradiation: a call to arms for physicists\u202f\u2013\u202fand radiotherapy vendors","volume":"182","author":"Vasquez Osorio","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijrobp.2024.12.023","article-title":"Software support tools for reirradiation: a report from Reirradiation Collaborative Group (ReCOG) 2024","volume":"122","author":"Matrosic","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104876_bib0065","article-title":"Automated planning of stereotactic spine reirradiation using cumulative dose limits","volume":"29","author":"Meyer","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109545","article-title":"Treatment plan optimisation for reirradiation","volume":"182","author":"Murray","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110741","article-title":"Radiobiologically equivalent deformable dose mapping for reirradiation planning: Implementation, robustness, and dosimetric benefits","volume":"205","author":"Garc\u00eda-Alvarez","year":"2025","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.radonc.2013.01.018","article-title":"Comparing rigid and deformable dose registration for high dose thoracic re-irradiation","volume":"106","author":"Senthi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109527","article-title":"Applicability and usage of dose mapping\/accumulation in radiotherapy","volume":"182","author":"Murr","year":"2023","journal-title":"Radiother Oncol"},{"issue":"24","key":"10.1016\/j.canrad.2026.104876_bib0090","doi-asserted-by":"crossref","first-page":"24TR01","DOI":"10.1088\/1361-6560\/ad0d8a","article-title":"Review and recommendations on deformable image registration uncertainties for radiotherapy applications","volume":"68","author":"Nenoff","year":"2023","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.canrad.2026.104876_bib0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2020.07.033","article-title":"Reirradiation in the thorax\u202f\u2013\u202fAn analysis of efficacy and safety based on accumulated EQD2 doses","volume":"152","author":"Schr\u00f6der","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.canrad.2024.08.002","article-title":"Tumor reirradiation: issues, challenges and perspectives for radiobiology","volume":"28","author":"No\u00ebl","year":"2024","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2004.06.016","article-title":"Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients","volume":"61","author":"Nieder","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/srao.2000.6593","article-title":"Tissue tolerance to reirradiation","volume":"10","author":"Nieder","year":"2000","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00066-021-01772-7","article-title":"New clinical data on human spinal cord reirradiation tolerance","volume":"197","author":"Doi","year":"2021","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00066-018-1266-6","article-title":"Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations","volume":"194","author":"Nieder","year":"2018","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","article-title":"Reirradiation human spinal cord tolerance for stereotactic body radiotherapy","volume":"82","author":"Sahgal","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ijrobp.2021.01.041","article-title":"International recommendations on reirradiation by intensity modulated radiation therapy for locally recurrent nasopharyngeal carcinoma","volume":"110","author":"Ng","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104876_bib0135","series-title":"Accumulated dose in clinical practice\u202f\u2013\u202fare we there yet? ESTRO meets Asia 2024 congress report","author":"Vasquez Osorio","year":"2024"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2017.12.013","article-title":"American Association of Physicists in Medicine Task Group 263: standardizing nomenclatures in radiation oncology","volume":"100","author":"Mayo","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104876_bib0145","unstructured":"Anon. Reirradiation FOCUS group. Brussels: European Society for Radiotherapy and Oncology; n.d. [Available online at: https:\/\/www.estro.org\/About\/ESTRO-Organisation-Structure\/Focus-Groups\/Reirradiation]."},{"key":"10.1016\/j.canrad.2026.104876_bib0150","unstructured":"recog.care\/home [homepage on the Internet]. Reirradiation Collaborative Group. URL: https:\/\/recog.care\/home."},{"key":"10.1016\/j.canrad.2026.104876_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canrad.2026.104798","article-title":"The French Reirradiation Team for Research and Treatment (FReTREAT): a national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France","volume":"30","author":"Beddok","year":"2026","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijrobp.2025.01.038","article-title":"Joining forces to advance reirradiation: establishing the Reirradiation COllaborative Group (ReCOG)","volume":"122","author":"Mayo","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104876_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110696","article-title":"ESTRO\/EANO recommendation on reirradiation of glioblastoma","volume":"204","author":"Andratschke","year":"2025","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0170","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG Oncology\/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma","volume":"41","author":"Tsien","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2018.01.011","article-title":"Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: a multicenter DKTK\/ROG analysis","volume":"127","author":"Niyazi","year":"2018","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0185","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1200\/JCO.22.01785","article-title":"Reirradiation for recurrent glioblastoma: what we know and what we do not","volume":"41","author":"Knisely","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109947","article-title":"Reirradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform","volume":"189","author":"Willmann","year":"2023","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0195","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2007.08.015","article-title":"Reirradiation tolerance of the human brain","volume":"70","author":"Mayer","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.canrad.2026.104876_bib0200","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/neuonc\/noad074","article-title":"Prognostic evaluation of reresection for recurrent glioblastoma using the novel RANO classification for extent of resection: a report of the RANO resect group","volume":"25","author":"Karschnia","year":"2023","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(92)91021-E","article-title":"Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment","volume":"24","author":"Gaspar","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0210","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2002.20.6.1635","article-title":"Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy","volume":"20","author":"Chan","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41582-021-00510-y","article-title":"MRI biomarkers in neuro-oncology","volume":"17","author":"Smits","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.canrad.2026.104876_bib0220","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.810263","article-title":"High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced MRI techniques in the clinic, and the latest bench-to-bedside developments. Part 1: perfusion and diffusion techniques","volume":"12","author":"Henriksen","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12885-016-2806-z","article-title":"Amino-acid PET versus MRI guided reirradiation in patients with recurrent glioblastoma multiforme (GLIAA)\u202f\u2013\u202fprotocol of a randomized phase II trial (NOA 10\/ARO 2013-1)","volume":"16","author":"Oehlke","year":"2016","journal-title":"BMC Cancer"},{"issue":"34","key":"10.1016\/j.canrad.2026.104876_bib0230","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1200\/JCO.2005.03.4157","article-title":"Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution","volume":"23","author":"Combs","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1748-717X-8-161","article-title":"Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort","volume":"8","author":"Scholtyssek","year":"2013","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-012-0999-9","article-title":"Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas","volume":"111","author":"Minniti","year":"2013","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0245","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11060-017-2611-9","article-title":"Salvage reirradiation for recurrent high-grade glioma and comparison to bevacizumab alone","volume":"135","author":"Arvold","year":"2017","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0250","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ijrobp.2010.12.074","article-title":"Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas","volume":"82","author":"Cuneo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-013-1126-2","article-title":"Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas","volume":"113","author":"McKenzie","year":"2013","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0260","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ijrobp.2024.01.013","article-title":"Prospective randomized phase 2 trial of hypofractionated stereotactic radiation therapy of 25 gy in 5 fractions compared with 35 Gy in 5 fractions in the reirradiation of recurrent glioblastoma","volume":"119","author":"Chen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2017.06.2466","article-title":"Multicenter, phase 1, dose escalation study of hypofractionated stereotactic radiation therapy with bevacizumab for recurrent glioblastoma and anaplastic astrocytoma","volume":"99","author":"Clarke","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.canrad.2026.104876_bib0270","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oncolo\/oyad095","article-title":"Hypofractionated stereotactic re-irradiation and anti-PDL1 durvalumab combination in recurrent glioblastoma: STERIMGLI phase I results","volume":"28","author":"Pouessel","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2026.104876_bib0275","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1748-717X-8-222","article-title":"Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience","volume":"8","author":"Ciammella","year":"2013","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11060-015-1825-y","article-title":"Reresection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better","volume":"124","author":"Palmer","year":"2015","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0285","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/neuros\/nyx629","article-title":"Moving second courses of radiotherapy forward: early reirradiation after surgical resection for recurrent gliomas improves efficacy with excellent tolerability","volume":"83","author":"Combs","year":"2018","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0290","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.canrad.2022.01.007","article-title":"Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: analysis of clinical and dosimetric data from a retrospective cohort of 184 patients","volume":"26","author":"Kuntz","year":"2022","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","article-title":"Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery","volume":"127","author":"McKay","year":"2017","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","article-title":"The evolving role of reirradiation in the management of recurrent brain tumors","volume":"164","author":"De Pietro","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/OTT.S60358","article-title":"Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study","volume":"7","author":"Greenspoon","year":"2014","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/cancers4020379","article-title":"External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain","volume":"4","author":"Sminia","year":"2012","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","article-title":"Current status and recent advances in reirradiation of glioblastoma","volume":"16","author":"Minniti","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0320","first-page":"132","article-title":"High-dose re-irradiation of intracranial lesions\u202f\u2013\u202fEfficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation","volume":"27","author":"Stiefel","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0325","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1748-717X-8-287","article-title":"Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma","volume":"8","author":"Niyazi","year":"2013","journal-title":"Radiat Oncol"},{"issue":"6-7","key":"10.1016\/j.canrad.2026.104876_bib0330","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.canrad.2022.06.016","article-title":"Reirradiation: a complex situation","volume":"26","author":"Chargari","year":"2022","journal-title":"Cancer Radiother"},{"issue":"10","key":"10.1016\/j.canrad.2026.104876_bib0335","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clon.2023.07.010","article-title":"Proton beam therapy in the reirradiation setting of brain and base of skull tumour recurrences","volume":"35","author":"Gaito","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0340","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","article-title":"Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies","volume":"30","author":"Simone","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0345","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fonc.2016.00180","article-title":"Brainstem glioma in adults","volume":"6","author":"Hu","year":"2016","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0350","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijrobp.2008.05.030","article-title":"The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study","volume":"73","author":"Janssens","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0355","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-020-03526-4","article-title":"Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma","volume":"148","author":"Bergman","year":"2020","journal-title":"J Neurooncol"},{"issue":"24","key":"10.1016\/j.canrad.2026.104876_bib0360","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/1078-0432.CCR-14-0951-T","article-title":"A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma","volume":"20","author":"Wick","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-008-9607-4","article-title":"Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas","volume":"89","author":"Combs","year":"2008","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0370","first-page":"44","article-title":"Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas","volume":"2","author":"Osman","year":"2014","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0375","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11060-010-0446-8","article-title":"Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma","volume":"103","author":"Minniti","year":"2011","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0380","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2018.12.043","article-title":"A phase 1\/2 trial of reirradiation for diffuse intrinsic pontine glioma","volume":"104","author":"Amsbaugh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104876_bib0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104261","article-title":"Decoding the puzzle: a multidisciplinary systematic review of adult brainstem glioma","volume":"196","author":"Ius","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0390","first-page":"305","article-title":"Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood","volume":"118","author":"Massimino","year":"2014","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1016\/j.canrad.2026.104876_bib0395","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00066-022-01913-6","article-title":"Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients: statistical analysis","volume":"198","author":"Kuntz","year":"2022","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0405","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3171\/2022.4.JNS212597","article-title":"Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases","volume":"138","author":"Sneed","year":"2022","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2026.104876_bib0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103043","article-title":"Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: systematic review and meta-analysis","volume":"153","author":"Loi","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.canrad.2026.104876_bib0415","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3171\/2016.6.GKS161404","article-title":"Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery","volume":"125","author":"Koiso","year":"2016","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-015-1937-4","article-title":"Repeated stereotactic radiosurgery for patients with progressive brain metastases","volume":"126","author":"Minniti","year":"2016","journal-title":"J Neurooncol"},{"issue":"3 Suppl","key":"10.1016\/j.canrad.2026.104876_bib0425","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0430","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mdh308","article-title":"Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience","volume":"15","author":"Brockstein","year":"2004","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0360-3016(89)90094-1","article-title":"Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience","volume":"17","author":"Cooper","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0440","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2016.03.015","article-title":"Reirradiation of head and neck cancers with intensity modulated radiation therapy: outcomes and analyses","volume":"95","author":"Takiar","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0445","first-page":"3165","article-title":"Reirradiation using intensity-modulated radiotherapy for recurrent and second primary head and neck Cancer","volume":"38","author":"Choi","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2026.104876_bib0450","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oraloncology.2016.06.017","article-title":"Predictors of severe long-term toxicity after re-irradiation for head and neck cancer","volume":"60","author":"Lee","year":"2016","journal-title":"Oral Oncol"},{"issue":"6-7","key":"10.1016\/j.canrad.2026.104876_bib0455","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.canrad.2019.07.147","article-title":"[Reirradiation for head and neck squamous cell carcinoma: indications and results]","volume":"23","author":"Biau","year":"2019","journal-title":"Cancer Radiother"},{"issue":"34","key":"10.1016\/j.canrad.2026.104876_bib0460","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","article-title":"Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma","volume":"26","author":"Janot","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0465","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00432-012-1313-0","article-title":"Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study","volume":"139","author":"Wang","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0470","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer\u202f\u2013\u202fsuccess and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0475","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.oraloncology.2012.08.013","article-title":"Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma","volume":"49","author":"Cao","year":"2013","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0485","doi-asserted-by":"crossref","first-page":"e91362","DOI":"10.1371\/journal.pone.0091362","article-title":"Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2013.08.012","article-title":"Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer","volume":"109","author":"Lartigau","year":"2013","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2026.104876_bib0495","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/hed.25892","article-title":"Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT\u202f\u2013\u202fA study by the HKNPCSG","volume":"41","author":"Ng","year":"2019","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0500","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/alr.22552","article-title":"Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis","volume":"10","author":"Yang","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0505","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hed.23719","article-title":"Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma","volume":"37","author":"Zou","year":"2015","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0510","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s10147-017-1143-9","article-title":"Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience","volume":"22","author":"Liu","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104876_bib0515","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ijrobp.2024.07.2143","article-title":"International recommendations on postoperative management for potentially resectable locally recurrent nasopharyngeal carcinoma","volume":"120","author":"Li","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0520","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijrobp.2017.06.012","article-title":"Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: a multi-institution cohort study by the MIRI Collaborative","volume":"100","author":"Ward","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0525","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2022.03.034","article-title":"Retreatment of recurrent or second primary head and neck cancer after prior radiation: executive summary of the American Radium Society Appropriate Use Criteria","volume":"113","author":"Ward","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0530","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/hed.25988","article-title":"Dose volume effects of reirradiation for locally recurrent nasopharyngeal carcinoma","volume":"42","author":"Ng","year":"2020","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0535","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/bjc.2013.715","article-title":"Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy","volume":"110","author":"Tian","year":"2014","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0540","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clon.2011.11.010","article-title":"Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy","volume":"24","author":"Han","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9","key":"10.1016\/j.canrad.2026.104876_bib0545","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.2017.75.5165","article-title":"Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy","volume":"36","author":"Li","year":"2018","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0550","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1007\/s00259-022-05793-x","article-title":"Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma","volume":"49","author":"Zhao","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2026.104876_bib0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110029","article-title":"Stereotactic reirradiation in the treatment of head and neck cancers: a retrospective study on the long-term experience of the Oscar-Lambret Center","volume":"190","author":"Delerue","year":"2024","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0560","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijrobp.2014.11.023","article-title":"A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck","volume":"91","author":"Vargo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.canrad.2026.104876_bib0565","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/lary.24441","article-title":"Adjuvant stereotactic body radiotherapy \u00b1 cetuximab following salvage surgery in previously irradiated head and neck cancer","volume":"124","author":"Vargo","year":"2014","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0570","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.ijrobp.2011.02.054","article-title":"A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma","volume":"81","author":"Ozyigit","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.canrad.2026.104876_bib0575","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.7314\/APJCP.2014.15.8.3561","article-title":"Reirradiation with robotic stereotactic body radiotherapy for recurrent nasopharyngeal carcinoma","volume":"15","author":"Dizman","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0580","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.radonc.2009.10.018","article-title":"Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma","volume":"93","author":"Seo","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0585","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ijrobp.2008.11.036","article-title":"Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma","volume":"75","author":"Leung","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0590","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00066-014-0809-8","article-title":"Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: long-term results","volume":"191","author":"Strnad","year":"2015","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0595","article-title":"Perioperative high dose rate brachytherapy in head and neck cancers: case report and review of clinical application","volume":"7","author":"Bahl","year":"2021","journal-title":"BJR Case Rep"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0600","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiology.213.2.r99nv29489","article-title":"Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy\u202f\u2013\u202fdose-volume histogram analysis","volume":"213","author":"Lin","year":"1999","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.canrad.2026.104876_bib0605","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00330-010-1784-9","article-title":"Comprehensive imaging of residual\/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT","volume":"20","author":"Ng","year":"2010","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0610","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0360-3016(97)00244-7","article-title":"Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement","volume":"38","author":"Lee","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0615","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00405-016-4339-0","article-title":"Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma","volume":"274","author":"Lee","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"Suppl. 1","key":"10.1016\/j.canrad.2026.104876_bib0620","first-page":"E1102","article-title":"Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience","volume":"38","author":"Karam","year":"2016","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0625","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1111\/ajco.12185","article-title":"Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: feasibility and complication","volume":"12","author":"Seo","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0630","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-3284-1-13","article-title":"Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis","volume":"1","author":"Chua","year":"2009","journal-title":"Head Neck Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0635","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2025.03.056","article-title":"American Radium Society Appropriate Use Criteria systematic review and guidelines on reirradiation for non-small cell lung cancer executive summary","volume":"123","author":"2nd","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0640","article-title":"An International expert survey on the indications and practice of radical thoracic reirradiation for non-small cell lung cancer","volume":"6","author":"Rulach","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0645","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/curroncol28030170","article-title":"Reirradiation for locally recurrent lung cancer: a single center retrospective analysis","volume":"28","author":"Grambozov","year":"2021","journal-title":"Curr Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.canrad.2026.104876_bib0650","first-page":"E961","article-title":"Reirradiation for second primary or recurrent cancers of the head and neck: dosimetric and outcome analysis","volume":"38","author":"Garg","year":"2016","journal-title":"Head Neck"},{"issue":"13","key":"10.1016\/j.canrad.2026.104876_bib0655","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.3390\/cancers13133173","article-title":"Re-irradiation for head and neck cancer: cumulative dose to organs at risk and late side effects","volume":"13","author":"Embring","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.canrad.2026.104876_bib0660","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hed.24733","article-title":"Reirradiation of head and neck cancer: long-term disease control and toxicity","volume":"39","author":"Bots","year":"2017","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0665","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ijrobp.2015.12.007","article-title":"Dosimetric factors and toxicity in highly conformal thoracic reirradiation","volume":"94","author":"Binkley","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0670","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2017.01.244","article-title":"Tolerance of the brachial plexus to high-dose reirradiation","volume":"98","author":"Chen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104876_bib0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2023.103914","article-title":"Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer\u202f\u2013\u202fA prospective study","volume":"44","author":"Apoorva","year":"2023","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0680","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0685","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hed.24645","article-title":"Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma","volume":"39","author":"Chan","year":"2017","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0690","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/lary.24218","article-title":"Whole-organ histopathological study of recurrent nasopharyngeal carcinoma","volume":"124","author":"Chan","year":"2014","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0695","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2010.08.029","article-title":"Risk of carotid blowout after reirradiation of the head and neck: a systematic review","volume":"82","author":"McDonald","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0700","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2013.05.005","article-title":"Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated reirradiation of head and neck cancer using CyberKnife: a multi-institutional study","volume":"107","author":"Yamazaki","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2026.104876_bib0705","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1748-717X-8-242","article-title":"A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers","volume":"8","author":"Yazici","year":"2013","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0710","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0360-3016(02)02711-6","article-title":"Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time","volume":"53","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2026.104876_bib0715","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-014-1513-3","article-title":"Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors","volume":"119","author":"Liu","year":"2014","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104876_bib0720","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40880-018-0338-4","article-title":"A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma","volume":"38","author":"Zou","year":"2018","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"10.1016\/j.canrad.2026.104876_bib0725","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ijrobp.2016.02.049","article-title":"Risk of severe toxicity according to site of recurrence in patients treated with stereotactic body radiation therapy for recurrent head and neck cancer","volume":"95","author":"Ling","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182600079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182600079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:03:42Z","timestamp":1791911022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832182600079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":145,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S127832182600079X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104876","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General technical considerations on reirradiation and focus on brain and head and neck tumours, suggestions from the Recommendations Commission of the Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104876"}}